XENOPORT INC 4

Accession 0000899243-16-024689

CIK 0001130591operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 9:43 PM ET

Size

24.4 KB

Accession

0000899243-16-024689

Form 4

Period: 2016-07-05

President

Transactions

Disposition from Tender
Common Stock
2016-07-05$7.03/sh−281,117$1,976,253→ 0 total(indirect: By Trust)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 total
Exercise: $6.04Exp: 2025-05-19→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 total
Exercise: $6.18Exp: 2022-05-16→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 total
Exercise: $4.35Exp: 2026-05-17→ Common Stock (15,000 underlying)
Disposition from Tender
Common Stock
2016-07-05$7.03/sh−31,660$222,570→ 0 total
Disposition from Tender
Common Stock
2016-07-05$7.03/sh−68$478→ 0 total(indirect: Through Fund)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−25,000$175,750→ 0 total
Exercise: $6.94Exp: 2020-09-17→ Common Stock (25,000 underlying)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 total
Exercise: $6.17Exp: 2023-05-14→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Options
2016-07-05$7.03/sh−15,000$105,450→ 0 total
Exercise: $4.57Exp: 2024-06-11→ Common Stock (15,000 underlying)
Disposition to Issuer
Restricted Stock Units
2016-07-05$7.03/sh−5,000$35,150→ 0 total
→ Common Stock (5,000 underlying)

Footnotes (5)

[F1]Shares held by the Rieflin Family Trust U/A dtd 04/03/00.
[F2]These shares represented William J. Rieflin's beneficial ownership as a limited partner in Skyline Venture Partners II, LP.
[F3]Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated May 21, 2016, by and among XenoPort, Inc. ("XenoPort"), Arbor Pharmaceuticals, LLC ("Arbor") and AP Acquisition Sub, Inc. ("AP Acquisition Sub"), a wholly owned subsidiary of Arbor, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding and unexercised option to purchase shares of common stock of XenoPort was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $7.03 per share minus (B) the exercise price per share of common stock of XenoPort.
[F4]Each restricted stock unit ("RSU") represents the right to receive one share of common stock of XenoPort.
[F5]Pursuant to the terms of the Merger Agreement, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding RSU was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to $7.03 per share.

Documents

1 file

XENOPORT INC

CIK 0001130591

Entity typeoperating

IncorporatedDE